Clinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
NCT02509845 is registered in ClinicalTrials.gov with Armata Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Microbiology of C16G2 Administered in Multiple Oral Gel Doses to Adolescent and Adult Dental Subjects
- Lead sponsor
- Armata Pharmaceuticals, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- March 31, 2016
- Enrollment
- 64 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.